A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

By
lbeveridge
-
0
72
Biochemical assays demonstrated that one of these peptides, PIP1, directly interacted with PELP1 to block PELP1 oncogenic functions.
[Cancer Research]
Abstract